Author

Angelus Cabanayan

University of California, Los Angeles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Christine A. Olson· 1 shared Elaine Y. HsiaoiD· 1 shared Graciel DiamanteiD· 1 shared Guanglin ZhangiD· 1 shared In‐Sook AhniD· 1 shared Ingrid Cely· 1 shared Justin G. YooniD· 1 shared Karen Garcia· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Christine A. Olson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cross-tissue multiomics reveals that Akkermansia muciniphila counteracts metabolic syndrome by reprograming gut microbiota, oleoylethanolamide and the gut-hypothalamus axis

Sung Min Ha, In‐Sook Ahn, Thomas Kowal, Justin G. Yoon, Christine A. Olson, Graciel Diamante, Ingrid Cely, Guanglin Zhang, Susana Wang, Karen Garcia, Zhejian Zhang, Angelus Cabanayan, Ruoshui Liu, Elaine Y. Hsiao, Xia Yang

This study identifies oleoylethanolamide (OEA) as a key mediator by which Akkermansia muciniphila alleviates fructose-induced metabolic syndrome through gut microbiota and gut-hypothalamus axis modulation.

bioRxiv · Sep 6, 2022 · PreprintSystems Biology